On April 29, 2013, a new analytical company was registered with the unified state register of legal entity. This company was RNC Pharma. Everything went well, and the company was registered in the Interdistrict Inspection of the Russian Federal Tax Service #46...

In February 2015, Russia imported 35.2 bln RUR worth of ready-made pharmaceutical drugs, with the import expenditures rising by 22%, compared to 2014. The actual volume of import has fallen by 8.5% over the year, continuing the trend that started in January. As for the preferred currency, we can see the previous year’s trends returning – the percentage of contracts concluded in rubles has risen from 90% in January to 94% in February...

In the current economic and political environment, import substitution is one of the key drivers of the Russian pharmaceutical market. Soon, we can expect more than 70 Russian alternatives to 30 INNs out of the 57 strategically important pharmaceutical drugs alone. RNC Pharma presents the results of the research of import substitution and localization in the Russian pharmaceutical market...

On March 26, Moscow hosted a Russian Association of Pharmaceutical Marketing (RAPM) conference, “New Threats and Opportunities of Russian Pharmaceutical Market in 2015”. Within the agenda of the conference, RNC Pharma published a forecast of the Russian pharmaceutical market after the monetary crisis of 2014-2015...

Rating of Russian pharmacy chains, following the results of 2014...